Edition:
India

Flexion Therapeutics Inc (FLXN.OQ)

FLXN.OQ on NASDAQ Stock Exchange Global Market

27.20USD
1:30am IST
Change (% chg)

$0.18 (+0.67%)
Prev Close
$27.02
Open
$27.03
Day's High
$27.45
Day's Low
$26.79
Volume
93,612
Avg. Vol
199,841
52-wk High
$32.22
52-wk Low
$19.07

Chart for

About

Flexion Therapeutics, Inc. is a United States-based specialty pharmaceutical company. The Company is focused on the development and commercialization of local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis. The Company's lead product... (more)

Overall

Beta: 1.14
Market Cap(Mil.): $954.94
Shares Outstanding(Mil.): 31.91
Dividend: --
Yield (%): --

Financials

BRIEF-Flexion Therapeutics Q1 Loss Per Share $1.10

* FLEXION THERAPEUTICS REPORTS FIRST-QUARTER 2018 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS

09 May 2018

BRIEF-Flexion Therapeutics Names David Arkowitz As Chief Financial Officer

* FLEXION THERAPEUTICS NAMES DAVID ARKOWITZ AS CHIEF FINANCIAL OFFICER

07 May 2018

BRIEF-Flexion Therapeutics Reports Q4 Sales $355,000

* FLEXION THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

09 Mar 2018

Earnings vs. Estimates